Angiolab, Inc. (XKON:251280)
South Korea · Delayed Price · Currency is KRW 3,200.00
+25.00 (0.79%)
At close: Sep 11, 2026
Angiolab Market Cap
Angiolab has a market cap or net worth of 11.17 billion as of September 11, 2026. Its market cap has decreased by -17.42% in one year.
Market Cap
11.17B
Enterprise Value
n/a
Revenue
702.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
3,200.00
ChartMarket Cap Chart
Since April 5, 2017, Angiolab's market cap has increased from 8.46B to 11.17B, an increase of 32.07%. That is a compound annual growth rate of 2.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 11.17B | 30.08% |
| Dec 30, 2025 | 8.59B | -62.64% |
| Dec 30, 2024 | 22.99B | 34.78% |
| Dec 28, 2023 | 17.06B | -12.06% |
| Dec 29, 2022 | 19.40B | -6.10% |
| Dec 30, 2021 | 20.66B | -31.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eutilex.Co.,Ltd | 35.32B |
| Quratis | 33.90B |
| Epibiotech | 30.43B |
| Shaperon | 23.58B |
| Poongjeon Pharmacy CO.,LTD. | 20.69B |
| Moogene Medi | 19.55B |
| Plumbline Life Sciences | 18.69B |
| NGeneBio | 11.29B |